Search Results: bipolar/ (2)

Director of cannabis research center says classification and political controversy are “obstacles to medical progress”
Dr. Igor Grant, director of the Center for Medicinal Cannabis Research (CMCR), and two other investigators published a study in the most recent issue of The Open Neurology Journal, which concluded that the Schedule I classification of marijuana is “not tenable.” The study further concluded that, “it is not accurate that cannabis has no medical value, or that information on safety is lacking.”
The study urges additional research, but states that marijuana’s federal classification and its political controversy are “obstacles to medical progress in this area.” The federal classification of marijuana is based on the government’s position that it has “no currently accepted medical use in treatment in the United States.”

‚ÄčMarijuana-like compounds can inhibit the multiplication of human immunodeficiency (HIV) virus in late-stage AIDS by acting on viral receptors. The results are from a new study were published by researchers from Mount Sinai School of Medicine in the journal PloS ONE.

Cannabis is used medicinally in diseases which are accompanied by appetite loss or by severe weight loss, and also for the management of chronic pain, symptoms that are usually present in the latter stages of AIDS, reports Cristian Mihon at Doctor Tipster.
Through this study, scientists learned that the cannabinoid receptors on the surface of immune cells, CB1 and CB2, are triggered by marijuana-like compounds and can inhibit the spread of HIV through the body. It’s crucial for scientists to know the effects of activating these CB1 and CB2 receptors, because that knowledge might be used in the future to develop new drugs that can slow the progression of AIDS.